COPD Diagnosis and Management

Diagnostic Criteria

The American Thoracic Society and European Respiratory Society recommend that COPD diagnosis requires three essential features: post-bronchodilator FEV1/FVC ratio <0.70, appropriate symptoms, and significant exposure to noxious stimuli such as cigarette smoking 1, 2
Spirometry is mandatory and must be performed post-bronchodilator to confirm persistent airflow limitation 3
Repeat spirometry is recommended for patients with initial FEV1/FVC ratios between 0.6-0.8 to account for day-to-day variability and increase diagnostic specificity 1, 2, 3

The GOLD system classifies airflow limitation severity into four grades based on post-bronchodilator FEV1 % predicted 5, 1, 2
Grade 1 (Mild): FEV1 ≥80% predicted 4, 5, 7
Grade 2 (Moderate): FEV1 50-79% predicted 4, 5, 7
Grade 3 (Severe): FEV1 30-49% predicted 4, 5, 7
Grade 4 (Very Severe): FEV1 <30% predicted 4, 5, 7

The current GOLD classification uses symptom burden and exacerbation history to assign patients to Groups A, B, C, or D, which directly determines treatment recommendations 1, 2, 8
Symptom assessment: low symptoms (mMRC 0-1 OR CAT <10) or high symptoms (mMRC ≥2 OR CAT ≥10) 4, 9, 5
Exacerbation risk assessment: low risk (0-1 moderate exacerbations per year) or high risk (≥2 moderate exacerbations OR ≥1 severe exacerbation requiring hospitalization per year) 4, 9, 8

Group A (Low Symptoms, Low Risk): short-acting bronchodilator as needed is the gold standard first-line treatment 3, 10, 8
Group B (High Symptoms, Low Risk): long-acting bronchodilator monotherapy is the first-line treatment 3, 10, 8
Group C (Low Symptoms, High Risk): LAMA monotherapy is preferred over LABA for exacerbation prevention 8
Group D (High Symptoms, High Risk): LAMA/LABA dual bronchodilator therapy is the gold standard first-line treatment, with superior exacerbation prevention and lower pneumonia risk compared to LABA/ICS 10, 8

Smoking cessation is the single most important intervention at all disease stages and the only treatment proven to prevent accelerated lung function decline 3, 10
Pulmonary rehabilitation is the gold standard for moderate to severe COPD, combining exercise training, nutritional support, and education 3, 10, 8
Annual influenza vaccination and pneumococcal vaccination are recommended for all COPD patients 3, 8
Long-term oxygen therapy is indicated for resting hypoxemia to improve survival 10, 8